Membranous Nephropathy: From the Discovery of an Antigen to a Novel Treatment

November 18, 2016 | 10:30 AM - 12:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

Add to Outlook Calendar Add to Google Calendar Add to Yahoo! Calendar Add to iCal Calendar

Clinical Practice Session

Membranous Nephropathy: From the Discovery of an Antigen to a Novel Treatment

November 18, 2016 | 10:30 AM - 12:30 PM

Location: W375A

Session Description

Circulating antibodies against glomerular antigens including phospholipase A2 receptor and thrombospondin type 1 domain-containing 7A have been found to be pathogenetic and can be predictive of disease activity and response to personalized therapies. This session highlights these recent developments in idiopathic membranous nephropathy.

Honorary Moderator: Richard J. Glassock, MD

Session Objectives

Upon completion of this session, the participant will be able to: 1. illustrate the most recent advancements in the pathophysiology of membranous nephropathy; 2. identify the new tool for monitoring disease activity; and 3. review new treatment regimens.

Session Acknowledgements

In celebration of its 50th anniversary, ASN thanks former ASN Councilor Richard J. Glassock, MD.

Learning Pathways

  • Glomerular Diseases
  • Novel Translational Approaches

Moderators

  • Christopher Patrick Larsen, MD
  • David J. Salant, MBChB, MD

Lectures

PLA2R and Other Novel Antigens Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
10:30 AM - 11:00 AM
Laurence H. Beck, MD, PhD

PLA2R Epitope Spreading and Disease Prognosis Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
11:00 AM - 11:30 AM
Gerard J. Lambeau, PhD

Clinical Use of Anti-PLA2R Antibodies Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
11:30 AM - 12:00 PM
Jack F. Wetzels, MD

Evolving Therapeutic Approach in Membranous Nephropathy Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
12:00 PM - 12:30 PM
Giuseppe Remuzzi, MD